Christopher P Larsen
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$5.2MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $5.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 12, 2026 | NIH | SBIR Phase I Precision Diagnostics in T-cell Mediated Rejection: Predicting Treatment Resistance at Time of Diagnosis | $267K | — |
| Aug 20, 2024 | NIH | SBIR Phase II A proprietary digital platform for precision patient identification and enrollment of clinical trials for rare kidney diseases | $950K | — |
| Sep 15, 2023 | NIH | SBIR Phase II A proprietary digital platform for precision patient identification and enrollment of clinical trials for rare kidney diseases | $976K | — |
| May 8, 2023 | NIH | SBIR Phase II Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy | $931K | — |
| Sep 12, 2022 | NIH | SBIR Phase II Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy | $1.0M | — |
| Sep 2, 2022 | NIH | SBIR Phase I Development of specific peptide reagents for serologic monitoring of Exostosin autoantibodies in membranous lupus nephritis | $259K | — |
| Sep 8, 2021 | NIH | SBIR Phase I Rapid Genotyping of ApoL1 Risk Alleles using CRISPR-Cas12a | $253K | — |
| Jul 2, 2021 | NIH | STTR Phase I Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy | $248K | — |
| Jul 26, 2019 | NIH | SBIR Phase I Development of biomarkers for improved classification of membranous lupus nephritis | $301K | — |
Peer ranks
Federal funding#63
Awards as PI#67
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.